FDA approves generic diabetes drug

Agency approves Macleods Pharma's pioglitazone hydrochloride tablets

SILVER SPRING, Md. - The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

The FDA approved Macleods' pioglitazone hydrochloride tablets in the 15 mg, 30 mg and 45 mg strengths.

The drug is a generic version of Takeda's Actos, branded and generic versions of which had sales of about $2.7 billion during the 12-month period that ended in August 2012, according to IMS Health.

Find us on Facebook for more insight, analysis and the latest in drug store news.

Login or Register to post a comment.